With respect to epithelial neoplasms, MYC amplification has been reported in approximately 50% of squamous cell carcinomas from immunosuppressed patients following organ transplantation, and diffuse nuclear MYC immunolabeling has been demonstrated in eyelid sebaceous carcinomas [60,61]. The gene discussed is MYC; the disease is squamous cell carcinoma.